Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 4/20 | 0.45 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.44 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.44 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.44 |
| ▸ | FEN1 | P39748 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MYC | P01106 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL430940 | 0.95 | NPC1 (0.46) | NPC1RAB9AHPGDKCNK3KCNK9 | |
| SCHEMBL2038760 | 0.84 | ACHE (0.53) | HPGDERCC5FEN1SMN1; SMN2ALDH1A1 | |
| SCHEMBL3461999 | 0.78 | NPC1 (0.44) | NPC1RAB9AHPGDKCNK3KCNK9 | |
| SCHEMBL4711341 | 0.76 | NPC1 (0.43) | NPC1RAB9AHPGDKCNK3KCNK9 | |
| SCHEMBL236 | 0.76 | AKR1C3 (0.61) | NPC1RAB9AHPGDKCNK3KCNK9 | |
| SCHEMBL6445437 | 0.76 | KMT2A (0.45) | NPC1RAB9AHPGDKCNK3KCNK9 | |
| SCHEMBL9451511 | 0.76 | AKR1C3 (0.61) | NPC1RAB9AHPGDKCNK3KCNK9 | |
| SCHEMBL11757827 | 0.76 | ALDH1A1 (0.49) | NPC1RAB9AHPGDKCNK3KCNK9 | |
| SCHEMBL11108075 | 0.76 | CYP1A2 (0.49) | NPC1RAB9AHPGDKCNK3KCNK9 | |
| SCHEMBL29402362 | 0.76 | AKR1C3 (0.61) | NPC1RAB9AHPGDKCNK3KCNK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 414 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118084988-A | Polymerization monomer for preparing beta-1, 3 glucan and polymerization method | 山东大学 | 2024-05-28 | — | — | CN | claimed |
| US-11827667-B2 | Production method for guanosine derivative having fluorine atom-containing functional group at position 8 and application thereof | UNIVERSITY OF MIYAZAKI (JP) | 2023-11-28 | — | — | US | claimed |
| CN-111925403-A | Glucosamine donors and application thereof | 山东大学 | 2020-11-13 | — | — | CN | claimed |
| US-8592214-B2 | Chemical reaction monitor | ILLUMINA, INC. (US) | 2013-11-26 | — | — | US | claimed |
| US-20130052690-A1 | PCR PRIMER AND METHOD FOR REDUCING NON-SPECIFIC NUCLEIC ACID AMPLIFICATION USING A PHOTOLABILE PROTECTING GROUP | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-02-28 | — | — | US | claimed |
| US-20110136684-A1 | CHEMICAL REACTION MONITOR | ILLUMINA, INC. | 2011-06-09 | — | — | US | claimed |
| US-7887752-B2 | Simultaneous data gathering for multiwell plates; light emitting diode illumination, camera image recording and computer storage and analysis; such as following dimethoxytrityl deprotection step during DNA chain synthesis to determine coupling efficiency | ILLUMINA, INC. (US) | 2011-02-15 | — | — | US | claimed |
| US-7718579-B2 | Electrochemical deblocking using a hydrazine derivative | COMBIMATRIX CORPORATION (US) | 2010-05-18 | — | — | US | claimed |
| EP-2045004-A1 | Method of manufacturing polymer array by coating photosensitizer | Samsung Electronics Co., Ltd. (KR) | 2009-04-08 | — | — | EP | claimed |
| EP-1805206-A2 | ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE | Combimatrix Corporation (US) | 2007-07-11 | — | — | EP | claimed |
| WO-2006031814-A2 | ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE | COMBIMATRIX CORPORATION (US) | 2006-03-23 | — | — | WO | claimed |
| US-20060054511-A1 | Electrochemical deblocking using a hydrazine derivative | CUSTOMARRAY, INC. | 2006-03-16 | — | — | US | claimed |
| WO-2006019471-A2 | FLUID PROCESSING DEVICE | APPLERA CORPORATION (US) | 2006-02-23 | — | — | WO | claimed |
| US-20060013742-A1 | Fluid processing device | APPLIED BIOSYSTEMS, LLC | 2006-01-19 | — | — | US | claimed |
| EP-1236736-A1 | 2-AMINOPURINE DERIVATIVES | HISAMITSU PHARMACEUTICAL CO. INC. (JP) | 2002-09-04 | — | — | EP | claimed |
| US-5221736-A | Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques | BIONEBRASKA, INC. (US) | 1993-06-22 | — | — | US | claimed |
| JP-60215685-A | — | — | None | — | — | JP | disclosed |
| WO-2024151257-A1 | NUCLEOTIDE EXTENSION CHAIN VERIFICATION | AGILENT TECHNOLOGIES, INC. (US) | 2024-07-18 | — | — | WO | disclosed |
| WO-1990006045-A2 | NUCLEIC ACID PROBES | DYNAL AS (NO) | 1990-06-14 | — | — | WO | disclosed |
| JP-S60215685-A | 2'-DEOXYARISTEROMYCIN DERIVATIVE AND ITS USE | TAKEDA CHEM IND LTD | 1985-10-29 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130052690-A1 | PCR PRIMER AND METHOD FOR REDUCING NON-SPECIFIC NUCLEIC ACID AMPLIFICATION USING A PHOTOLABILE PROTECTING GROUP | POLL, POLRMT, POLN | NPC1 3926/4885RAB9A 3856/4885HPGD 2897/4885 |
| US-11827667-B2 | Production method for guanosine derivative having fluorine atom-containing functional group at position 8 and application thereof | RNMT, FBL, NOP2 | NPC1 2063/4885RAB9A 1390/4885HPGD 1034/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.